Track the 纳微科技 share price and the full directors' dealings record of the company, a listed equity based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 纳微科技 has published 22 reports. Market capitalisation: €13.6bn. The latest transaction was disclosed on 24 December 2024 (Sale). Among the most active insiders: 牟一萍. All data is accessible without an account.
22
Insider Decl.
n/a
Thresholds
€428,458
16 ops.
Buy Volume
€20m
6 ops.
Sell Volume
23Σ signal
Buys €428,458€20m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,097 of 29,062 companies
52.8
score / 100
Value
27
Quality
78
FCF yld0.6%
Earn yld1.0%
EV/EBITDA52.3x
ROE8.8%
Gross mgn71%
Net mgn15%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
纳微科技 is a company operating in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It specializes in the development of innovative technologies and products for the medical field.